CSF2 and melanoma: Similar to TriMix, a vaccination strategy utilizing cyclic dinucleotides, to activate the STING pathway, in addition to GM-CSF-secreting tumors mediates regression of established melanoma [150] and enhances the efficacy of anti-PD-1 antibody therapy [151].